Hyperlipoproteinemia Type 1
2 clinical trials · Condition
◉ Watch Hyperlipoproteinemia Type 1
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS) (NCT03360747) | Akcea Therapeutics | 2017-12-21 |
| The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome (NCT02658175) | Akcea Therapeutics | 2015-12-23 |
Track Hyperlipoproteinemia Type 1 automatically
Every clearance here is in the API, with alerts when new ones post.